Similarly, blockade of GSK-3β by antisense oligonucleotides ameliorated AD symptoms in SAMP8 mice, a mouse model that displays increased Aβ levels, tau hyperphosphorylation, and cognitive deficits (Farr et al., 2014). Here, MAPT is linked to Alzheimer disease.